Seasonal Influenza and Pneumococcal Polysaccharide Vaccination (SIPPV)

Camden
Add to CPD
Under Review — this page was due to be reviewed by Thursday, 01 April 2021. The information shown here may be outdated.

Seasonal Influenza and Pneumococcal Polysaccharide Vaccination (SIPPV)

The pneumococcal element of this DES is effective from 1 April 2020 to 31 March 2021. The patients eligible for pneumococcal vaccination under this DES are those who are previously unvaccinated with PPV23 since aged two, who are:

  • aged 65 and over.
  • aged two to 64 years

Some GP computer systems are giving the following high severity warning for influenza vaccination: “Drug to Drug interaction. Avoid antivirals for at least 2 weeks after immunisation; avoid immunisation for at least 48 hours after stopping the antiviral.” The HIV Pharmacy Association of the UK advise that there is no interaction between the flu vaccine and antiretrovirals. Patients with HIV patients should:

  • have a flu vaccine, as advised in Department of Health guidelines
  • NOT STOP their antiretrovirals

Campaign materials for Stay Well This Winter are still available. 

Specification Document

Seasonal Influenza and Pneumococcal Polysaccharide Vaccination (SIPPV) specification 2020-21

PDF, 247.14 KB


Last updated: Tuesday, 21 June 2022
Review date: Thursday, 01 April 2021